These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 30905652)

  • 1. Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis.
    Fernández J; Clària J; Amorós A; Aguilar F; Castro M; Casulleras M; Acevedo J; Duran-Güell M; Nuñez L; Costa M; Torres M; Horrillo R; Ruiz-Del-Árbol L; Villanueva C; Prado V; Arteaga M; Trebicka J; Angeli P; Merli M; Alessandria C; Aagaard NK; Soriano G; Durand F; Gerbes A; Gustot T; Welzel TM; Salerno F; Bañares R; Vargas V; Albillos A; Silva A; Morales-Ruiz M; Carlos García-Pagán J; Pavesi M; Jalan R; Bernardi M; Moreau R; Páez A; Arroyo V
    Gastroenterology; 2019 Jul; 157(1):149-162. PubMed ID: 30905652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis.
    Fernández J; Navasa M; Garcia-Pagan JC; G-Abraldes J; Jiménez W; Bosch J; Arroyo V
    J Hepatol; 2004 Sep; 41(3):384-90. PubMed ID: 15336440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
    Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised study.
    Hobolth L; Bendtsen F; Hansen EF; Møller S
    Dig Liver Dis; 2014 Mar; 46(3):251-6. PubMed ID: 24290869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Sapropterin on Portal and Systemic Hemodynamics in Patients With Cirrhosis and Portal Hypertension: A Bicentric Double-Blind Placebo-Controlled Study.
    Reverter E; Mesonero F; Seijo S; Martínez J; Abraldes JG; Peñas B; Berzigotti A; Deulofeu R; Bosch J; Albillos A; García-Pagán JC
    Am J Gastroenterol; 2015 Jul; 110(7):985-92. PubMed ID: 26077176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of different therapeutic modalities on systemic, renal, and hepatic hemodynamics and short-term outcomes in cirrhotic patients with spontaneous bacterial peritonitis.
    Salman TA; Edrees AM; El-Said HH; El-Abd OL; El-Azab GI
    Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):777-85. PubMed ID: 27097354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of probiotic therapy on portal pressure in patients with cirrhosis: a pilot study.
    Tandon P; Moncrief K; Madsen K; Arrieta MC; Owen RJ; Bain VG; Wong WW; Ma MM
    Liver Int; 2009 Aug; 29(7):1110-5. PubMed ID: 19490420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial.
    Solà E; Solé C; Simón-Talero M; Martín-Llahí M; Castellote J; Garcia-Martínez R; Moreira R; Torrens M; Márquez F; Fabrellas N; de Prada G; Huelin P; Lopez Benaiges E; Ventura M; Manríquez M; Nazar A; Ariza X; Suñé P; Graupera I; Pose E; Colmenero J; Pavesi M; Guevara M; Navasa M; Xiol X; Córdoba J; Vargas V; Ginès P
    J Hepatol; 2018 Dec; 69(6):1250-1259. PubMed ID: 30138685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic derangement in human immunodeficiency virus-infected patients with hepatitis C virus-related cirrhosis: the role of bacterial translocation.
    Montes-de-Oca M; Blanco MJ; Marquez M; Soto MJ; Fernandez-Gutiérrez C; Rodriguez-Ramos C; Giron-Gonzalez JA
    Liver Int; 2011 Jul; 31(6):850-8. PubMed ID: 21645216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
    Tan HK; James PD; Wong F
    Dig Dis Sci; 2016 Oct; 61(10):3084-3092. PubMed ID: 27048451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension.
    Schepke M; Werner E; Biecker E; Schiedermaier P; Heller J; Neef M; Stoffel-Wagner B; Hofer U; Caselmann WH; Sauerbruch T
    Gastroenterology; 2001 Aug; 121(2):389-95. PubMed ID: 11487548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study.
    Guevara M; Terra C; Nazar A; Solà E; Fernández J; Pavesi M; Arroyo V; Ginès P
    J Hepatol; 2012 Oct; 57(4):759-65. PubMed ID: 22732511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: long-term hemodynamic and renal effects.
    Morillas RM; Planas R; Cabré E; Galán A; Quer JC; Feu F; García Pagán JC; Bosch J; Gassull MA
    Hepatology; 1994 Dec; 20(6):1502-8. PubMed ID: 7982651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating nitric oxide products do not solely reflect nitric oxide release in cirrhosis and portal hypertension.
    Afzelius P; Bazeghi N; Bie P; Bendtsen F; Vestbo J; Møller S
    Liver Int; 2011 Oct; 31(9):1381-7. PubMed ID: 21745317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized study of losartan vs propranolol: Effects on hepatic and systemic hemodynamics in cirrhotic patients.
    Castaño G; Viudez P; Riccitelli M; Sookoian S
    Ann Hepatol; 2003; 2(1):36-40. PubMed ID: 15094704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of verapamil on hepatic and systemic hemodynamics and liver function in patients with cirrhosis and portal hypertension.
    Navasa M; Bosch J; Reichen J; Bru C; Mastai R; Zysset T; Silva G; Chesta J; Rodés J
    Hepatology; 1988; 8(4):850-4. PubMed ID: 3391511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of valsartan, an angiotensin II receptor antagonist, on portal and systemic hemodynamics and on renal function in liver cirrhosis.
    Fierbinteanu-Braticevici C; Dragomir P; Tribus L; Negreanu L; Bengus A; Usvat R; Andronescu D
    J Gastrointestin Liver Dis; 2006 Dec; 15(4):337-42. PubMed ID: 17205144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis.
    Lens S; Alvarado-Tapias E; Mariño Z; Londoño MC; LLop E; Martinez J; Fortea JI; Ibañez L; Ariza X; Baiges A; Gallego A; Bañares R; Puente A; Albillos A; Calleja JL; Torras X; Hernández-Gea V; Bosch J; Villanueva C; Forns X; García-Pagán JC
    Gastroenterology; 2017 Nov; 153(5):1273-1283.e1. PubMed ID: 28734831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial.
    Gupta N; Kumar A; Sharma P; Garg V; Sharma BC; Sarin SK
    Liver Int; 2013 Sep; 33(8):1148-57. PubMed ID: 23601333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of long-term albumin therapy in the treatment of decompensated cirrhosis.
    Khanna D; Kar P; Sahu P
    Indian J Gastroenterol; 2024 Apr; 43(2):494-504. PubMed ID: 38722510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.